These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17446073)

  • 1. Synthesis and biological evaluation of an 123I-labeled bicyclic nucleoside analogue (BCNA) as potential SPECT tracer for VZV-tk reporter gene imaging.
    Chitneni SK; Deroose CM; Fonge H; Gijsbers R; Dyubankova N; Balzarini J; Debyser Z; Mortelmans L; Verbruggen AM; Bormans GM
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3458-62. PubMed ID: 17446073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A p-[18F]fluoroethoxyphenyl bicyclic nucleoside analogue as a potential positron emission tomography imaging agent for varicella-zoster virus thymidine kinase gene expression.
    Chitneni SK; Deroose CM; Balzarini J; Gijsbers R; Celen S; Debyser Z; Mortelmans L; Verbruggen AM; Bormans GM
    J Med Chem; 2007 Dec; 50(26):6627-37. PubMed ID: 18047266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preliminary evaluation of 18F- or 11C-labeled bicyclic nucleoside analogues as potential probes for imaging varicella-zoster virus thymidine kinase gene expression using positron emission tomography.
    Chitneni SK; Deroose CM; Balzarini J; Gijsbers R; Celen SJ; de Groot TJ; Debyser Z; Mortelmans L; Verbruggen AM; Bormans GM
    J Med Chem; 2007 Mar; 50(5):1041-9. PubMed ID: 17298046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.
    McGuigan C; Derudas M; Quintiliani M; Andrei G; Snoeck R; Henson G; Balzarini J
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6264-7. PubMed ID: 19833513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET.
    Deroose CM; Chitneni SK; Gijsbers R; Vermaelen P; Ibrahimi A; Balzarini J; Baekelandt V; Verbruggen A; Nuyts J; Debyser Z; Bormans GM; Mortelmans L
    Nucl Med Biol; 2012 Nov; 39(8):1266-74. PubMed ID: 22981986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bicyclic nucleoside inhibitors of varicella-zoster virus modified on the sugar moiety: 3' and 5' derivatives.
    Luoni GM; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2004 Nov; 15(6):333-41. PubMed ID: 15646647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of unusual bicyclic nucleosides bearing an unsaturated side-chain, as potential inhibitors of varicella-zoster virus (VZV).
    Bidet O; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):817-9. PubMed ID: 14565286
    [No Abstract]   [Full Text] [Related]  

  • 9. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.
    Sienaert R; Andrei G; Snoeck R; De Clercq E; McGuigan C; Balzarini J
    Biochem Biophys Res Commun; 2004 Mar; 315(4):877-83. PubMed ID: 14985094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicyclic nucleoside inhibitors of varicella-zoster virus: 5'-chloro and 3'-chloro derivatives.
    Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):931-3. PubMed ID: 14565314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclic nucleoside inhibitors of varicella-zoster virus: synthesis and biological evaluation of 2',3'-dideoxy-3'-fluoro and 2'-deoxy-xylo derivatives.
    Carangio A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):935-7. PubMed ID: 14565315
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines.
    Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J
    J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bicyclic furanopyrimidines with dual anti-VZV and -HCMV activity.
    McGuigan C; Brancale A; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4511-3. PubMed ID: 14643358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue.
    Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C
    Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.
    McGuigan C; Pathirana RN; Migliore M; Adak R; Luoni G; Jones AT; Díez-Torrubia A; Camarasa MJ; Velázquez S; Henson G; Verbeken E; Sienaert R; Naesens L; Snoeck R; Andrei G; Balzarini J
    J Antimicrob Chemother; 2007 Dec; 60(6):1316-30. PubMed ID: 17956908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine.
    Russ P; Schelling P; Scapozza L; Folkers G; Clercq ED; Marquez VE
    J Med Chem; 2003 Nov; 46(23):5045-54. PubMed ID: 14584954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains.
    Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C
    J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): Pd-catalysed synthesis of 5-aryl derivatives and their biological evaluation.
    Carangio A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2001 May; 12(3):187-97. PubMed ID: 12959327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV).
    Sienaert R; Naesens L; Brancale A; Carangio A; Andrei G; Snoeck R; Van Kuilenburg A; De Clercq E; McGuigan C; Balzarini J
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):995-7. PubMed ID: 14565329
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents.
    Wang ZX; Duan W; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(1-2):41-58. PubMed ID: 11303562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.